A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Journal of drugs in dermatology : JDD

Volumn 5, Issue 9, 2006, Pages 863-866

  Holcomb, Katherine ^a   Weinberg, Jeffrey M ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VACCINE; VARICELLA ZOSTER VACCINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HERPES ZOSTER; HUMAN; IMMUNOLOGY; INCIDENCE; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; VARICELLA ZOSTER VIRUS;

HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HERPESVIRUS VACCINES; HUMANS; INCIDENCE; NEURALGIA, POSTHERPETIC; RANDOMIZED CONTROLLED TRIALS;

EID: 33750935175     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)